Indexado em
  • Genamics JournalSeek
  • JournalTOCs
  • CiteFactor
  • Diretório de Periódicos de Ulrich
  • RefSeek
  • Universidade de Hamdard
  • EBSCO AZ
  • Diretório de Indexação de Resumos para Periódicos
  • OCLC- WorldCat
  • publons
  • Fundação de Genebra para Educação e Pesquisa Médica
  • Euro Pub
  • Google Scholar
Compartilhe esta página
Folheto de jornal
Flyer image

Abstrato

A Comparative Evaluation of Systemic Azithromycin and Ornidazole - Ofloxacin Combination as an Adjunct to Scaling and Root Planing In the Treatment of Chronic Generalised Periodontitis

Apurva Boid*,Sangeeta Muglikar,Rashmi Hegde

Background: It is a well-established fact that various periodontal diseases are caused by bacteria, some of which are tissue invasive. It has been suggested that an antibiotic strength 500 times greater than the usual therapeutic dose may be needed to be effective against bacteria arranged in biofilm. However, so far, the literature shows that the ideal treatment is mechanical removal of local factors followed by systemic anti-infective therapy.

Aims and Objective: To evaluate and compare the clinical effects of systemic Azithromycin (AZM) and Ornidazole-Ofloxacin combination as an adjunct to Scaling and Root Planning in the treatment of patients with chronic periodontitis.

Materials and Method: This was a comparative randomized clinical Study in which 30 patients with chronic periodontitis participated. Patients were randomly divided into 3 groups: The group1 received Scaling and Root Planning plus Azithromycin, group 2received Scaling and Root Planning plus Ornidazole?Ofloxacin combination and the group 3 (control) which received Scaling and Root Planning only. Clinical indices including Probing Pocket Depth (PPD), Relative Attachment Level (RAL), Gingival Index (GI), and Plaque Index (PI) were measured at the baseline, 4 and 8weeks after treatment.

Results: Comparison of the clinical parameters showed statistically significant improvement in all the three groups. SRP plus Azithromycin group showed additional benefit than SRP plus Ornidazole-Ofloxacin and SRP alone.

Isenção de responsabilidade: Este resumo foi traduzido usando ferramentas de inteligência artificial e ainda não foi revisado ou verificado